Publication date: June 2018
Source:Journal of the American Academy of Dermatology, Volume 78, Issue 6
Author(s): Deep Joshipura, Abdulaziz Alomran, Pedro Zancanaro, David Rosmarin
https://ift.tt/2s3MLTL
Τετάρτη 23 Μαΐου 2018
Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open-label extension study with optional narrow-band ultraviolet B
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου